Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis

Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: an overview of systematic reviews with meta-analysis

BackgroundUnipolar and bipolar depression present treatment challenges, with patients sometimes showing limited or no response to standard medications. Ketamine and its enantiomer, esketamine, offer promising alternative treatments that can quickly relieve suicidal thoughts. This Overview of Reviews...

Full description

Bibliographic Details
Main Authors:	Alessandro Rodolico, Pierfelice Cutrufelli, Antonio Di Francesco, Andrea Aguglia, Gaetano Catania, Carmen Concerto, Alessandro Cuomo, Andrea Fagiolini, Giuseppe Lanza, Ludovico Mineo, Antimo Natale, Laura Rapisarda, Antonino Petralia, Maria Salvina Signorelli, Eugenio Aguglia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Series:	Frontiers in Psychiatry
Subjects:	unipolar depression bipolar depression ketamine esketamine suicidal ideation treatment resistance
Online Access:	https://www.frontiersin.org/articles/10.3389/fpsyt.2024.1325399/full

Similar Items

Exploration of mood spectrum symptoms during a major depressive episode: The impact of contrapolarity—Results from a transdiagnostic cluster analysis on an Italian sample of unipolar and bipolar patients
by: Ludovico Mineo, et al.
Published: (2022-01-01)

Diagnosis of unipolar and bipolar depressions and their specifiers
by: Itiana Castro Menezes, et al.
Published: (2017-02-01)

Clinical efficacy and tolerability of Esketamine: a case series
by: C. Passani, et al.
Published: (2022-06-01)

Characteristics of unipolar depression in psychiatric inpatients
by: M. Kacem, et al.
Published: (2021-04-01)

Treating with esketamine nasal, will increase blood pressure?
by: V. Rosello-Molina, et al.
Published: (2021-04-01)

Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression
by: D. Hernandez Huerta, et al.
Published: (2022-06-01)

A Systematic Review on the Effect of Nutraceuticals on Antidepressant-Induced Sexual Dysfunctions: From Basic Principles to Clinical Applications
by: Carmen Concerto, et al.
Published: (2022-07-01)

Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments
by: Antimo Natale, et al.
Published: (2022-01-01)

The role of intranasal esketamine in treatment-resistant depression
by: A. Fraga, et al.
Published: (2021-04-01)

Executive functions in young patients with unipolar depression
by: Totić-Poznanović Sanja, et al.
Published: (2006-01-01)

Esketamine and Psilocybin—The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review
by: Dominika Psiuk, et al.
Published: (2022-09-01)

C-reactive protein as a biomarker for unipolar versus bipolar depression: a cross-sectional study
by: Hani Hamed Dessoki, et al.
Published: (2023-08-01)

Heterogeneous trajectory of depressive symptoms after repeated subcutaneous esketamine injections
by: Matheus Ghossain Barbosa, et al.
Published: (2021-01-01)

How effective are ketamine or esketamine in treatment-resistant depression?
by: N. Veluri, et al.
Published: (2021-04-01)

Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression
by: Lorena Catarina Del Sant, et al.
Published: (2022-12-01)

A STUDY COMPARING SOCIO-DEMOGRAPHIC AND CLINICAL PROFILE OF PATIENTS OF UNIPOLAR AND BIPOLAR DEPRESSION.
by: Dr. Farheen fatma, et al.
Published: (2023-09-01)

Gait disorders in unipolar and bipolar depression
by: Diana Bogdanova
Published: (2023-05-01)

Cognitive distortions and perfectionism during bipolar and unipolar depressive episode
by: Ayşe Ergüner Aral, et al.
Published: (2023-11-01)

Case report: Intranasal esketamine for severe major depressive disorder with psychotic features
by: Maximilian Carter, et al.
Published: (2022-07-01)

Neurobiology and Applications of Inositol in Psychiatry: A Narrative Review
by: Carmen Concerto, et al.
Published: (2023-02-01)

Analysis of Seasonal Clinical Characteristics in Patients With Bipolar or Unipolar Depression
by: Shuqi Kong, et al.
Published: (2022-04-01)

Overcoming the myths of esketamine administration: different and not difficult
by: Florian Buchmayer, et al.
Published: (2023-11-01)

Editorial: New trends in the treatment of mood disorders
by: Carmen Concerto, et al.
Published: (2024-01-01)

Global Trends and Hotspots in Esketamine Research: A Bibliometric Analysis of Past and Estimation of Future Trends
by: Li X, et al.
Published: (2022-04-01)

Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
by: Liu P, et al.
Published: (2022-12-01)

Montgomery‐Åsberg Depression Rating Scale factors in treatment‐resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine
by: Stephane Borentain, et al.
Published: (2022-12-01)

Esketamine pretreatment during cesarean section reduced the incidence of postpartum depression: a randomized controlled trail
by: Shixia Xu, et al.
Published: (2024-01-01)

Early real-life evaluation of the efficacy of esketamine in resistant depressive disorder
by: S. Faisant, et al.
Published: (2022-06-01)

The drug liking and craving questionnaire (DLCQ) to evaluate addiction risk for ketamine and esketamine
by: Jay Wang, et al.
Published: (2022-03-01)

Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders
by: Miriam Olivola, et al.
Published: (2022-02-01)

Effect of postoperative application of esketamine on postoperative depression and postoperative analgesia in patients undergoing pancreatoduodenectomy: a randomized controlled trial protocol
by: Kaili Yu, et al.
Published: (2023-08-01)

Short-term cognitive effects of repeated-dose esketamine in adolescents with major depressive disorder and suicidal ideation: a randomized controlled trial
by: Xiaofeng Lan, et al.
Published: (2023-09-01)

Association between symptoms of unipolar depression and metabolic syndrome in a tertiary care hospital
by: Md Munnawar S Hussain, et al.
Published: (2019-01-01)

Intranasal Esketamine + CBT: a 6 months follow-up of a resistant depression complicated case
by: V. Martiadis, et al.
Published: (2022-06-01)

Effect of Sleep Disturbance on Efficacy of Esketamine in Treatment-Resistant Depression: Findings from Randomized Controlled Trials
by: Borentain S, et al.
Published: (2021-11-01)

A comparison between patients who suffer from major depression and are treated with Esketamine – one group participates in group therapy and the other one does not
by: H. Yaniv, et al.
Published: (2022-06-01)

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
by: Ludivine Boudieu, et al.
Published: (2023-12-01)

Similar and Different Regional Homogeneity Changes Between Bipolar Disorder and Unipolar Depression: A Resting-State fMRI Study
by: Liu P, et al.
Published: (2020-04-01)

Effect of esketamine on postoperative depressive symptoms in patients undergoing thoracoscopic lung cancer surgery: A randomized controlled trial
by: Shu-lin Gan, et al.
Published: (2023-03-01)

The efficacy and safety of esketamine in the treatment of major depressive disorder with suicidal ideation: study protocol for a randomized controlled trial
by: Haiyan Liu, et al.
Published: (2022-11-01)